Literature DB >> 21631192

Harvey Cushing and pediatric brain tumors at Johns Hopkins: the early stages of development.

Courtney Pendleton1, Edward S Ahn, Alfredo Quiñones-Hinojosa.   

Abstract

OBJECT: Harvey Cushing, credited with pioneering the field of neurosurgery as a distinct surgical subspecialty in the US, was at the forefront of neurooncology, publishing seminal papers on the diagnosis and treatment of pediatric brain tumors during the latter part of his career. However, his contributions to the surgical treatment of these lesions during the early stages of his tenure at the Johns Hopkins Hospital, from 1896 to 1912, remain largely unknown.
METHODS: After obtaining institutional review board approval, and through the courtesy of the Alan Mason Chesney Archives, the authors reviewed the Johns Hopkins Hospital surgical files from the years 1896 to 1912. Patients younger than 18 years of age, presenting with symptoms suspicious for an intracranial tumor, and undergoing surgical intervention by Cushing were selected for further analysis.
RESULTS: Of the 40 pediatric patients undergoing surgery for suspected intracranial neoplasms, 26 were male. The mean age among the entire sample was 10.1 years. Cushing used three main operative approaches in the surgical treatment of pediatric intracranial neoplasms: infratentorial/suboccipital, subtemporal, and hemisphere flap. Twenty-three patients had negative findings following both the primary and subsequent surgical interventions conducted by Cushing. Postoperative conditions following the primary surgical intervention were improved in 24 patients. Twelve patients (30%) died during their inpatient stay for the primary intervention. The mean time to the last follow-up was 24.9 months; the mean time to death was 10.0 months.
CONCLUSIONS: Cushing strove to maximize exposure while minimizing blood loss in an attempt to increase his ability to successfully treat pediatric brain tumors. His early contributions to the field of pediatric neurooncology demonstrate his commitment to advancing the field of neurosurgery.

Entities:  

Mesh:

Year:  2011        PMID: 21631192      PMCID: PMC4618461          DOI: 10.3171/2011.3.PEDS10323

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  7 in total

Review 1.  Brain tumors: from childhood through adolescence into adulthood.

Authors:  Mark W Kieran; David Walker; Didier Frappaz; Michael Prados
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Diagnosis and surgical treatment of childhood brain tumors.

Authors:  C B Wilson
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

3.  An Address on the Surgery of the Brain and Spinal Cord.

Authors:  W Macewen
Journal:  Br Med J       Date:  1888-08-11

4.  Localization and William Macewen's early brain surgery Part II: The cases.

Authors:  Malcolm Macmillan
Journal:  J Hist Neurosci       Date:  2005-03       Impact factor: 0.529

Review 5.  Gliomas: quo vadis.

Authors:  James T Rutka; Astrid Weyerbrock; Muh Lii Liang
Journal:  Clin Neurosurg       Date:  2006

6.  Some of Harvey's Cushing's contributions to neurological surgery.

Authors:  G Horrax
Journal:  J Neurosurg       Date:  1981-04       Impact factor: 5.115

Review 7.  Surgical management of pediatric brain tumors.

Authors:  Gregory G Heuer; Eric M Jackson; Suresh N Magge; Phillip B Storm
Journal:  Expert Rev Anticancer Ther       Date:  2007-12       Impact factor: 4.512

  7 in total
  2 in total

Review 1.  Recent technological advances in pediatric brain tumor surgery.

Authors:  Bassel Zebian; Francesco Vergani; José Pedro Lavrador; Soumya Mukherjee; William John Kitchen; Vita Stagno; Christos Chamilos; Benedetta Pettorini; Conor Mallucci
Journal:  CNS Oncol       Date:  2016-12-21

2.  Illustrated dynamic stories behind pediatric neurosurgery.

Authors:  Voramol Rochanaroon; Danil A Kozyrev; Jonathan Roth; Shlomi Constantini
Journal:  Surg Neurol Int       Date:  2019-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.